Pharma Stocks
-
Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Sideways Trend
Technical Trend Overview and Price Movement The stock closed at ₹8,896.00 on 31 Dec 2025, down 1.50% from the previous…
Read More » -
Why Everyone Is Suddenly Watching This Pharma Underdog
Lupin Ltd is quietly ripping in the pharma game while socials wake up late. Is this sleeper stock a must-cop…
Read More » -
Research And Views Archives | Equitymaster
ABOUT EQUITYMASTER Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid…
Read More » -
3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains – December 30, 2025
Key Takeaways JNJ, ABBV and MRK are featured as large-cap pharma stocks offering dividends and long-term stability. Pricing deals and…
Read More » -
BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees
NEW YORK, December 29, 2025, 23:20 ET — Market closed Brand Engagement Network shares closed up 108.8% on Monday after…
Read More » -
Why Is Inovio Pharma Stock Sinking Monday? – Inovio Pharmaceuticals (NASDAQ:INO)
Inovio Pharmaceuticals Inc. (NASDAQ:INO) stock fell Monday after the U.S. Food and Drug Administration accepted the company’s Biologics License Application…
Read More » -
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Mixed Price Action
Open Interest and Volume Dynamics On 29 Dec 2025, Sun Pharma’s open interest (OI) in derivatives rose sharply to 91,032…
Read More » -
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target
GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. HSBC Sees Pharma Poised to…
Read More » -
Bal Pharma Ltd Stock Falls to 52-Week Low of Rs.67.15
Stock Price Movement and Market Context On 29 Dec 2025, Bal Pharma Ltd’s stock price touched Rs.67.15, the lowest level…
Read More » -
Trading of Beximco Pharma on London to be suspended from 2 January
Trading of global depositary receipts (GDRs) of Beximco Pharmaceuticals will be temporarily suspended on London’s Alternative Investment Market (AIM) from…
Read More »